{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:07:01Z","timestamp":1779206821005,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004162","name":"Meath Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001594","name":"Irish Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001637","name":"Trinity College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003840","name":"Irish Institute of Clinical Neuroscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jns.2025.123540","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T10:50:58Z","timestamp":1747479058000},"page":"123540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pilot study of on-treatment platelet reactivity at low shear stress and platelet activation status on aspirin or clopidogrel monotherapy in patients with TIA or ischaemic stroke"],"prefix":"10.1016","volume":"475","author":[{"given":"S.T.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.X.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-Y.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.H.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2025.123540_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.60.2.197","article-title":"Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia","volume":"60","author":"Algra","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123540_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J. Neurol. Sci."},{"issue":"10042","key":"10.1016\/j.jns.2025.123540_bb0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(16)30468-8","article-title":"Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials","volume":"388","author":"Rothwell","year":"2016","journal-title":"Lancet"},{"issue":"9038","key":"10.1016\/j.jns.2025.123540_bb0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jns.2025.123540_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2025.123540_bb0035","article-title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","volume":"363","author":"Hao","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2025.123540_bb0040","article-title":"Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline","volume":"363","author":"Prasad","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2025.123540_bb0045","author":"Pan","year":"2019","journal-title":"JAMA Neurol."},{"issue":"26","key":"10.1016\/j.jns.2025.123540_bb0050","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","article-title":"Dual antiplatelet treatment up to 72 hours after ischemic stroke","volume":"389","author":"Gao","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"10123","key":"10.1016\/j.jns.2025.123540_bb0055","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(17)32849-0","article-title":"Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial","volume":"391","author":"Bath","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.jns.2025.123540_bb0060","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"9431","key":"10.1016\/j.jns.2025.123540_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jns.2025.123540_bb0070","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"SPS3 Investigators","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejvs.2022.04.011","article-title":"Editor\u2019s choice - European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease","volume":"65","author":"Naylor","year":"2023","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"5","key":"10.1016\/j.jns.2025.123540_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/09537104.2015.1049139","article-title":"Platelet function testing in transient ischaemic attack and ischaemic stroke: a comprehensive systematic review of the literature","volume":"26","author":"Lim","year":"2015","journal-title":"Platelets"},{"issue":"10","key":"10.1016\/j.jns.2025.123540_bb0085","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1007\/s00415-020-09932-y","article-title":"Platelet function\/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis","volume":"267","author":"Lim","year":"2020","journal-title":"J. Neurol."},{"issue":"9066","key":"10.1016\/j.jns.2025.123540_bb0090","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"9065","key":"10.1016\/j.jns.2025.123540_bb0095","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jns.2025.123540_bb0100","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.07.012","article-title":"Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100\u00ae and VerifyNow\u00ae","volume":"22","author":"Kinsella","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.jns.2025.123540_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1468-1331.2012.03861.x","article-title":"High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the TRinity AntiPlatelet responsiveness (TRAP) study","volume":"20","author":"Tobin","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2025.123540_bb0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2141.2010.08539.x","article-title":"Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TRAP) study","volume":"152","author":"Tobin","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.jns.2025.123540_bb0115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.STR.0000064326.65899.AC","article-title":"Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study","volume":"34","author":"Grau","year":"2003","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jns.2025.123540_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clinthera.2008.02.006","volume":"30","author":"Serebruany","year":"2008","journal-title":"Clin. Ther."},{"issue":"12","key":"10.1016\/j.jns.2025.123540_bb0125","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/j.1538-7836.2004.01046.x","article-title":"Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100","volume":"2","author":"Raman","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.jns.2025.123540_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals","volume":"45","author":"Serebruany","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.jns.2025.123540_bb0135","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.STR.0000181081.09262.e1","article-title":"Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix use for treatment of stroke (PLUTO-stroke) trial","volume":"36","author":"Serebruany","year":"2005","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jns.2025.123540_bb0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejphar.2004.07.114","article-title":"Magnitude and time course of platelet inhibition with Aggrenox and aspirin in patients after ischemic stroke: the AGgrenox versus aspirin therapy evaluation (AGATE) trial","volume":"499","author":"Serebruany","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.jns.2025.123540_bb0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejvs.2021.10.045","article-title":"Platelet biomarkers in patients with atherosclerotic extracranial carotid artery stenosis: a systematic review","volume":"63","author":"Subramanian","year":"2022","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.jns.2025.123540_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120334","article-title":"Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke","volume":"441","author":"Lim","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00415-019-09550-3","article-title":"Relationship between \u2018on-treatment platelet reactivity\u2019, shear stress, and micro-embolic signals in asymptomatic and symptomatic carotid stenosis","volume":"267","author":"Murphy","year":"2020","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2025.123540_bb0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","author":"European Stroke Organisation Executive Committee","year":"2008","journal-title":"Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/09537104.2020.1850670","article-title":"Profile of reticulated platelets in the early, subacute and late phases after transient ischemic attack or ischemic stroke","volume":"33","author":"Lim","year":"2022","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000352050","article-title":"The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping)","volume":"36","author":"Amarenco","year":"2013","journal-title":"Cerebrovasc. Dis."},{"issue":"12","key":"10.1016\/j.jns.2025.123540_bb0180","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jns.2025.123540_bb0185","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.2004.04983.x","article-title":"Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack","volume":"125","author":"McCabe","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.jns.2025.123540_bb0190","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/jth.12277","article-title":"Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the platelets and carotid stenosis study","volume":"11","author":"Kinsella","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.jns.2025.123540_bb0195","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/01.STR.0000126474.25720.3e","article-title":"Measurement of the antiplatelet effects of aspirin in cerebrovascular disease","volume":"35","author":"McCabe","year":"2004","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2025.123540_bb0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/09537100400020567","article-title":"Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA","volume":"16","author":"McCabe","year":"2005","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5114\/aoms.2015.49211","article-title":"Searching for factors associated with resistance to acetylsalicylic acid used for secondary prevention of stroke","volume":"11","author":"\u0141abuz-Roszak","year":"2015","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0210","first-page":"35","article-title":"Aspirin resistance May not be associated with clinical outcome after acute ischemic stroke: comparison with three different platelet function assays. Korean","volume":"14","author":"Yoo","year":"2012","journal-title":"J. Stroke"},{"key":"10.1016\/j.jns.2025.123540_bb0215","first-page":"907","article-title":"Mohamed Ibrahim Norlinah biochemical aspirin resistance in stroke patients \u2013 a cross-sectional single Centre study","volume":"12","author":"Azmin","year":"2013","journal-title":"EXCLI J."},{"issue":"2","key":"10.1016\/j.jns.2025.123540_bb0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/ejh.12406","article-title":"The clinical utility of multiplate analyser measurement in platelet function testing following stroke and transient ischaemic attack","volume":"94","author":"Mannu","year":"2015","journal-title":"Eur. J. Haematol."},{"issue":"8","key":"10.1016\/j.jns.2025.123540_bb0225","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MBC.0b013e3283655640","article-title":"Factors influencing multiplate whole blood impedance platelet aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study","volume":"24","author":"Jastrzebska","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"3","key":"10.1016\/j.jns.2025.123540_bb0230","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.thromres.2013.12.002","article-title":"Clopidogrel high-on-treatment platelet reactivity in acute ischemic stroke patients","volume":"133","author":"Meves","year":"2014","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.jns.2025.123540_bb0235","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.06.024","article-title":"Clopidogrel resistance after minor ischemic stroke or transient ischemic attack is associated with radiological cerebral small-vessel disease","volume":"24","author":"Lundstrom","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"3\u20134","key":"10.1016\/j.jns.2025.123540_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000438722","article-title":"Interest of antiplatelet drug testing after an acute ischemic stroke","volume":"74","author":"Coignion","year":"2015","journal-title":"Eur. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2025.123540_bb0245","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jacc.2005.05.090","article-title":"Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation","volume":"46","author":"Tantry","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.jns.2025.123540_bb0250","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ahj.2009.02.013","article-title":"Aspirin noncompliance is the major cause of \u201caspirin resistance\u201d in patients undergoing coronary stenting","volume":"157","author":"Cuisset","year":"2009","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.jns.2025.123540_bb0255","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.112.117283","article-title":"Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin","volume":"127","author":"Grosser","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jns.2025.123540_bb0260","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/j.1538-7836.2010.03997.x","article-title":"The role of weight and enteric coating on aspirin response in cardiovascular patients","volume":"8","author":"Peace","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.jns.2025.123540_bb0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00043798-199604000-00013","article-title":"Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women","volume":"3","author":"Ridker","year":"1996","journal-title":"J. Cardiovasc. Risk"},{"issue":"8","key":"10.1016\/j.jns.2025.123540_bb0270","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.STR.0000231683.43347.ec","article-title":"Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers","volume":"37","author":"Cox","year":"2006","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2025.123540_bb0275","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/hrt.2009.181107","article-title":"The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease","volume":"96","author":"Wurtz","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jns.2025.123540_bb0280","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2690","article-title":"Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study","volume":"342","author":"Charlot","year":"2011","journal-title":"BMJ"},{"issue":"10145","key":"10.1016\/j.jns.2025.123540_bb0285","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jns.2025.123540_bb0290","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.ehj.2004.07.036","article-title":"High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability","volume":"25","author":"Angiolillo","year":"2004","journal-title":"Eur. Heart J."},{"issue":"14","key":"10.1016\/j.jns.2025.123540_bb0295","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.jns.2025.123540_bb0300","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/09537104.2010.499483","article-title":"Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy","volume":"21","author":"Armero","year":"2010","journal-title":"Platelets"},{"issue":"23","key":"10.1016\/j.jns.2025.123540_bb0305","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.jns.2025.123540_bb0310","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1161\/CIRCULATIONAHA.106.643171","article-title":"Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?","volume":"114","author":"O\u2019Donoghue","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0315","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ahj.2011.03.026","article-title":"Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use","volume":"162","author":"Voora","year":"2011","journal-title":"Am. Heart J."},{"issue":"11","key":"10.1016\/j.jns.2025.123540_bb0320","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/j.1538-7836.2011.04482.x","article-title":"Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes","volume":"9","author":"Postula","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.jns.2025.123540_bb0325","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0330","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of Clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jns.2025.123540_bb0340","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2141.2001.02620.x","article-title":"In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib","volume":"112","author":"Meiklejohn","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.jns.2025.123540_bb0345","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/09537104.2018.1445839","article-title":"Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders","volume":"29","author":"Bath","year":"2018","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0350","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/svn-2020-000346","article-title":"Remote platelet function testing using P-selectin expression in patients with recent cerebral ischaemia on clopidogrel","volume":"6","author":"Appleton","year":"2021","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.jns.2025.123540_bb0355","article-title":"Remote assessment of platelet function in patients with acute stroke or transient Ischaemic attack","volume":"2017","author":"Bath","year":"2017","journal-title":"Stroke Res. Treat."},{"issue":"1","key":"10.1016\/j.jns.2025.123540_bb0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2796.1990.tb00111.x","article-title":"Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction","volume":"227","author":"D\u2019Erasmo","year":"1990","journal-title":"J. Intern. Med."},{"issue":"6","key":"10.1016\/j.jns.2025.123540_bb0365","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/01.STR.26.6.995","article-title":"Platelet size in stroke patients","volume":"26","author":"O\u2019Malley","year":"1995","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jns.2025.123540_bb0370","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/09537109876429","article-title":"The relationship between mean platelet volume, stroke subtype and clinical outcome","volume":"9","author":"Butterworth","year":"1998","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.jns.2025.123540_bb0375","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.STR.0000116105.26237.EC","article-title":"Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease","volume":"35","author":"Bath","year":"2004","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.jns.2025.123540_bb0380","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1161\/01.STR.0000130512.81212.a2","article-title":"Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?","volume":"35","author":"Greisenegger","year":"2004","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2025.123540_bb0385","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/ATVBAHA.110.221788","article-title":"Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease","volume":"31","author":"Slavka","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.jns.2025.123540_bb0390","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001721-199603000-00011","article-title":"Platelet size: measurement, physiology and vascular disease","volume":"7","author":"Bath","year":"1996","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"6","key":"10.1016\/j.jns.2025.123540_bb0395","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/09537109777050","article-title":"Reticulated platelets","volume":"8","author":"Harrison","year":"1997","journal-title":"Platelets"}],"updated-by":[{"DOI":"10.1016\/j.jns.2025.123646","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000}}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:52:16Z","timestamp":1762210336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":79,"alternative-id":["S0022510X25001571"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123540","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot study of on-treatment platelet reactivity at low shear stress and platelet activation status on aspirin or clopidogrel monotherapy in patients with TIA or ischaemic stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123540"}}